Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

THE LAWSUIT: A class action securities lawsuit was filed against Moderna, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 18, ...

ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration: Vancouver, British Columbia Friday, September 20, 2024, 14:00 Hrs [IST] ME ...

Merck ’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value.

A groundbreaking discovery by Victorian scientists could pave the way for stronger Covid vaccines, that better protect ...

A new cancer vaccine, mRNA-4359, utilizing mRNA technology similar to Covid-19 vaccines, has yielded encouraging results in ...

Japan's health ministry has approved five types of coronavirus vaccines for use in this season's campaign that starts on October 1.

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic disorders and cancer due to ...